Digital Transformation

As Northern Virginia home prices jump over 7%, strategic kitchen and bath renovations offer homeowners some of the highest returns on their investment.

With record results and a pivot to oil, the Calgary firm is accelerating its growth targets and challenging the status quo in Canada's prized Duvernay play.

A brief delay in Avidity's stockholder vote signals the final, complex steps before its acquisition by Novartis and the launch of a new spin-off.

A five-year pivot from office buildings to luxury apartments culminates in a blockbuster private buyout, validating a risky strategy and igniting the market.

ITF Therapeutics will unveil 10 new data presentations on its Duchenne therapy, DUVYZAT, offering critical new insights on long-term safety and efficacy.

A new app aims to reduce the burden on families by centralizing care, medical, and long-term financial plans in one secure platform.

After halting all R&D, PCI Biotech proposes dissolution and delisting, marking the end for its novel drug delivery platform and a warning for investors.

Friction and heat are destroying your mower's engine. A new checklist from Toro shows how a simple annual check-up can prevent costly spring breakdowns.

Madison Capital Group offers a new DST for a luxury Asheville community, tapping a hot market facing a surge in supply and evolving economic crosscurrents.

With its newly approved VIZZ eye drop, LENZ Therapeutics is wooing investors, aiming to capture a slice of the massive, underserved presbyopia market.

Following a series of acquisitions, Southwest Strategies Group rebrands as Bodewell, positioning itself to manage public consent for a new era of US infrastructure.

January data shows a massive jump in corporate financing requests, hinting at a busy year for investment, while the municipal market tells a different story.

A patent-pending tubing anchor catcher is showing early promise, with reports of 100% production gains by tackling stubborn gas interference issues.

With its lead CAR-T therapy, Descartes-08, in late-stage trials, Cartesian Therapeutics is set to update investors on its pioneering work in autoimmune disease.

A new high-grade discovery deep beneath a century-old mine could revive a legendary BC mining district and bolster Canada's critical mineral supply.

A new three-tube collection system from BD promises to improve accuracy, streamline lab work, and enhance patient safety by reducing sample contamination.

A new platform by Dr. Jess Ingrassellino launches to demystify music tech, empowering a new generation of electric string players and their teachers.

Lindsay unveils the Road Runner TMA, an attenuator designed for unmatched durability, rapid deployment, and cost savings to protect road crews.

The biotech firm slashed a major acquisition hurdle in a deal with HealthCare Royalty, signaling strong confidence in its cancer drug ZYNLONTA's future.

El Salvador is overhauling its customs with Smiths Detection's high-speed X-ray scanners, aiming to curb illicit trade and accelerate commerce.